Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xenetic Biosciences Inc (NASDAQ:XBIO)

3.51
Delayed Data
As of 10:29am ET
 +0.23 / +7.01%
Today’s Change
2.70
Today|||52-Week Range
7.92
-18.37%
Year-to-Date
No recent news for Xenetic Biosciences Inc.

Today’s Trading

Previous close3.28
Today’s open3.94
Day’s range3.51 - 3.95
Volume22,223
Average volume (3 months)16,022
Market cap$28.3M
Dividend yield--
Data as of 10:29am ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)-163.97%
Earnings growth (this year)+88.65%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales10.65
Price/Book1.69

Competitors

 Today’s
change
Today’s
% change
VICLVical Inc+0.01+0.44%
HTBXHeat Biologics Inc-0.05-6.42%
MRNSMarinus Pharmaceutic...+0.02+1.72%
AXNAoxing Pharmaceutica...-0.02-5.37%
Data as of 10:44am ET, 05/23/2017

Financials

Last reporting dateMay 16, 2017
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$3.0M
Annual profit (last year)-$54.2M
Net profit margin-1,806.87%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael Scott Maguire
Chief Operating Officer &
Director
Jeffrey F. Eisenberg
Corporate headquarters
Lexington, Massachusetts

Forecasts